Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2010-03-24 Board/Management Inform…
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Board/Management Information 2010
Board/Management Information Classification · 99% confidence The document is a short announcement (854 characters) dated March 24, 2010, from BLUE VISION A/S. The key content is the announcement that the Board of Directors has entered into a contract with Vilhelm Boas to serve as the full-time CEO, effective March 23, 2010. This directly relates to a change in senior management personnel. This aligns perfectly with the definition for Board/Management Information (MANG). It is not a full report, earnings release, or dividend notice.
2010-03-24 English
Regulatory Filings 2010
Regulatory Filings
2010-03-24 Danish
Regulatory Filings 2010
Regulatory Filings
2010-03-24 Danish
M&A Activity 2010
M&A Activity Classification · 99% confidence The document is a short announcement (1223 characters) from BLUE VISION A/S dated February 2, 2010, titled 'MARKEDSMEDDELELSE' (Market Announcement). The content explicitly discusses the postponement ('UDSKYDELSE') of the closing date for a previously announced transaction (acquisition of shares in Strandpromenaden A/S). Since this is a short, specific announcement regarding a corporate action (a transaction/acquisition) that doesn't fit the definitions for ER, IR, 10-K, or DIV, and it is not a general regulatory filing (RNS) or a report publication announcement (RPA) in the sense of announcing a full report, it most closely relates to corporate activity or financing. Given the context of a transaction/acquisition, it falls under M&A Activity (TAR) or potentially Capital/Financing Update (CAP). Since it specifically concerns the closing of a share acquisition, TAR (M&A Activity) is the most precise fit, as it relates to a merger/takeover proposal or related transaction.
2010-03-24 English
Legal Proceedings Report 2010
Legal Proceedings Report Classification · 99% confidence The document is a 'MARKEDSMEDDELELSE' (Market Announcement) from Blue Vision A/S dated March 16, 2010. The content explicitly states that the Board of Directors is being reported to the police ('politianmeldelse') based on a recommendation from the Danish Financial Supervisory Authority ('Finanstilsynet') regarding a violation of disclosure timing rules (§ 14 in the Takeover Bids Regulation) related to a previous takeover bid. This concerns a regulatory/legal matter involving the company and a supervisory body. This fits best under 'Legal Proceedings Report' (LTR) as it details an official action/complaint against the board based on regulatory non-compliance, or potentially 'Regulatory Filings' (RNS) as a general regulatory announcement. Given the specific nature of reporting the board for a violation following a regulatory body's recommendation, LTR is the most precise fit, as it relates to significant legal/regulatory action against the company/management.
2010-03-16 English
Regulatory Filings 2010
Regulatory Filings
2010-03-16 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.